Search research articles
Contact Us
Filters
Showing results (351-360 of 374) with videos related to
Page
of 38
Sort By:
QJM : Monthly Journal of the Association of Physicians
|
April 30, 2014
Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes
M Makatsori, S Kiani-Alikhan, A L Manson, et al.
Bone Marrow Transplantation
|
June 27, 2017
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation
J Pavlů, H W Auner, R M Szydlo, et al.
Bone Marrow Transplantation
|
November 23, 2006
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre
J B Perz, C Giles, R Szydlo, et al.
Blood
|
June 22, 2010
Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma
Ian H Gabriel, Ruhena Sergeant, Richard Szydlo, et al.
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
British Journal of Cancer
|
October 9, 1998
High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels
E J Kanfer, D McGuigan, D Samson, et al.
Bone Marrow Transplantation
|
May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
A J Innes, R Beattie, R Sergeant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2017
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
U De Giorgi, S Richard, M Badoglio, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 14, 2018
Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies
Julie Beckerson, Richard M Szydlo, Mary Hickson, et al.
Haematologica
|
October 26, 2010
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade, Paula Garland, Takuya Sekine, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 374) with videos related to
Sort By:
Page
of 38
QJM : Monthly Journal of the Association of Physicians
|
April 30, 2014
Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes
M Makatsori, S Kiani-Alikhan, A L Manson, et al.
Bone Marrow Transplantation
|
June 27, 2017
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation
J Pavlů, H W Auner, R M Szydlo, et al.
Bone Marrow Transplantation
|
November 23, 2006
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre
J B Perz, C Giles, R Szydlo, et al.
Blood
|
June 22, 2010
Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma
Ian H Gabriel, Ruhena Sergeant, Richard Szydlo, et al.
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
British Journal of Cancer
|
October 9, 1998
High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels
E J Kanfer, D McGuigan, D Samson, et al.
Bone Marrow Transplantation
|
May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
A J Innes, R Beattie, R Sergeant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2017
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
U De Giorgi, S Richard, M Badoglio, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 14, 2018
Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies
Julie Beckerson, Richard M Szydlo, Mary Hickson, et al.
Haematologica
|
October 26, 2010
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade, Paula Garland, Takuya Sekine, et al.
Page
of 38